EPISODE · May 7, 2026 · 7 MIN
肠镜检查后新型口服抗凝药（DOAC）恢复用药的时机
from 消化肝病前沿资讯
本期播客聚焦肠镜检查后新型口服抗凝药（DOAC）的恢复时机这一临床难题，探讨推迟用药虽想降低出血风险，却可能增加血栓风险的矛盾。通过美国近8000例患者研究，发现延迟恢复组血栓风险显著升高，而出血风险未明显下降。节目解析研究设计与局限，指出应更重视血栓风险，转变临床思维，为高凝患者及常规检查者提供更安全的管理参考。00:06肠镜后DOAC恢复存争议00:45研究分组与核心问题01:37高风险人群研究结果02:33血栓风险增出血未降03:26临床悖论与风险评估04:18研究局限与证据现状05:02改变思维重视血栓险05:43寻找最佳恢复时机06:45老龄化下更需谨慎
Embed this episode
NOW PLAYING
肠镜检查后新型口服抗凝药（DOAC）恢复用药的时机
0:00
7:15
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 消化肝病前沿资讯?
This episode is 7 minutes long.
When was this 消化肝病前沿资讯 episode published?
This episode was published on May 7, 2026.
Can I download this 消化肝病前沿资讯 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!